跳至主要内容
临床试验/EUCTR2008-001325-34-IT
EUCTR2008-001325-34-IT进行中(未招募)不适用

PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMI

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2008年6月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Age > 18 y
  • 2.Acute myocardial infarction (STEMI) with ST segment elevation in at least two contiguous leads and thoracic pain lasting over 20 minutes and less than 6 hours
  • 3.Informed Consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Acute myocardial infarction without ST elevation (NSTEMI)
  • 2.Complete left bundle branch block
  • 3.Previous STEMI in the same territory
  • 4.Contraindications to anti-platelet therapy or IIb/IIIa inhibitors
  • 5.Hypertension (> 180/100 mmHg)
  • 6.Pregnancy or fertile age

研究者

发起方
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

相似试验

PROMISE AMI (PROtection of coronary Microcirculation... | 临床试验